The Disturbance of Hepatic and Serous Lipids in Aristolochic Acid Ι Induced Rats for Hepatotoxicity Using Lipidomics Approach
Open Access
Abstract
Aristolochic acid I (AAI) was regarded as the major toxic component of aristolochic acid (AA). In addition to aristolochic acid nephropathy (AAN), liver cancers induced by AAI has aroused increasing attention recently. In this paper, the discovery of diagnostic biomarkers for AAI-induced liver injury has been studied, especially for the lipid markers. From the histopathological characteristics, the injury was observed clearly in the liver apart from the kidney after 30 mg/kg of AAΙ treatment for one week, while the lesion alleviated after AAΙ discontinuance. The serum biochemical indexes were manifested to the normal tendency after AAΙ discontinuance for two weeks. According to the evaluation of pathology slices and serum biochemical indexes, they indicated that the hepatotoxicity induced by AAΙ was reversible to some extent. A total of 44 lipid markers were identified in the liver, as well as 59 in the serum. Twenty-six common lipid markers were observed in both serum and liver. Furthermore, nine out of 26 lipids exhibited the excellent diagnostic ability to differentiate the control group from the AAΙ group and AAΙ discontinuance group with high sensitivity and specificity. The changed lipid markers might serve as characteristics to explain the mechanisms of pathogenesis and progression in hepatotoxicity induced by AAΙ.Keywords
Funding Information
- National Science and Technology Major Project (2018ZX09101002-003, 2015ZX09501004-003-001)
- China Academy of Chinese Medical Sciences Foundation (ZZ10-025 and ZZ12-001)
- the Major International S&T Cooperation Project from Ministry of Science and Technology of the People’s Republic of China (No. 2016YFE0129000)
This publication has 40 references indexed in Scilit:
- Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cellsToxicology in Vitro, 2012
- On the future of “omics”: lipidomicsJournal of Inherited Metabolic Disease, 2011
- Toxicities of aristolochic acid I and aristololactam I in cultured renal epithelial cellsToxicology in Vitro, 2010
- Lipidomics: Developments and applicationsJournal of Chromatography B, 2009
- Bioactive sphingolipids: metabolism and functionJournal of Lipid Research, 2009
- β-Glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic ratAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- A lipidomic analysis of nonalcoholic fatty liver diseaseHepatology, 2007
- Glucocerebroside Ameliorates the Metabolic Syndrome in OB/OB MiceThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitisHepatology, 1999
- Glucosylceramides stimulate murine epidermal hyperproliferation.Journal of Clinical Investigation, 1995